Landos Biopharma, Inc.

NasdaqCM:LABP Stock Report

Market Cap: US$71.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Landos Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LABP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders00%
Private Companies8960.0287%
Institutions128,7774.12%
General Public1,200,08538.4%
VC/PE Firms1,796,08357.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 61.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.6%
Perceptive Advisors LLC
1,486,991US$34.1m0%0.66%
9.89%
Xontogeny LLC
309,092US$7.1m0%no data
1.6%
Deltec Asset Management LLC
50,000US$1.1m0%0.23%
0.6%
Renaissance Technologies LLC
18,890US$433.1k67.8%no data
0.47%
Macquarie Investment Management Business Trust
14,718US$337.5k0%no data
0.47%
Virtu Financial LLC, Asset Management Arm
14,537US$333.3k0%0.03%
0.4%
Geode Capital Management, LLC
12,604US$289.0k0%no data
0.33%
Black Maple Capital Management LP
10,405US$238.6k0%0.16%
0.13%
UBS Asset Management AG
4,084US$93.6k9,620%no data
0.077%
The Vanguard Group, Inc.
2,399US$55.0k0%no data
0.029%
Tower Research Capital LLC
896US$20.5k0%no data
0.019%
Bg Fund Management Luxembourg S.A.
606US$13.9k0%no data
0.0078%
GF Fund Management Co., Ltd.
243US$5.6k0%no data
0.0043%
Acadian Asset Management LLC
134US$3.1k0%no data
0.0019%
Royal Bank of Canada, Banking & Securities Investments
61US$1.4k0%no data
0.0019%
JPMorgan Chase & Co, Brokerage and Securities Investments
59US$1.4k0%no data
0.00042%
Morgan Stanley, Investment Banking and Brokerage Investments
13US$301.00%no data
0.00038%
Cornerstone Planning Group Inc.
12US$272.40%no data
0.00032%
Wells Fargo & Company, Private Banking and Investment Banking Arm
10US$229.40%no data
0.00006%
Guggenheim Partners, LLC
2US$43.00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/26 22:58
End of Day Share Price 2024/05/24 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Landos Biopharma, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robin Garner KalleyCraig-Hallum Capital Group LLC
Raghuram SelvarajuH.C. Wainwright & Co.
Christopher HowertonJefferies LLC